Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy
ACTIVE_NOT_RECRUITING
Status
Conditions
- Colorectal Cancer Stage II
- Colorectal Cancer Stage III
Interventions
- PROCEDURE: Regular blood sample collection for ctDNA assessment
Sponsor
BioNTech SE